Clinical Trial

Cervical Erector Spinae Plane Block for Dyspnea in Acute Respiratory Failure: A Prospective Cohort

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 19, 2025 (before its estimated March 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
Dyspnea is common and distressing in patients with acute respiratory failure. In our intensive care unit, some patients receive a cervical erector spinae plane (ESP) block to help relieve dyspnea. This study will observe patients who receive bilateral cervical ESP blocks and measure changes in dyspnea using validated scales at predefined time points over 24 hours. We will also track vital signs, arterial blood gas values, and diaphragm movement on ultrasound.
Trial Details
NCT Number NCT07182695
Lead Sponsor Hacettepe University
Conditions Acute Respiratory Failure (ARF), Dyspnea
Enrollment 30 participants
Start Date 2025-09-15
Primary Completion 2026-03-15 (estimated)
Study Completion 2026-03-15 (estimated)
Updated on ClinicalTrials.gov 2025-09-19